Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H1, 2015

Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2664CTIDB
  • |
  • Pages: 89
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H1, 2015" provides data on the Exocrine Pancreatic Insufficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Exocrine Pancreatic Insufficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Exocrine Pancreatic Insufficiency. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Exocrine Pancreatic Insufficiency 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Exocrine Pancreatic Insufficiency 25

Subjects Recruited Over a Period of Time 28

Clinical Trials by Sponsor Type 29

Prominent Sponsors 30

Top Companies Participating in Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials 31

Prominent Drugs 32

Clinical Trial Profiles 33

Clinical Trial Overview of Top Companies 33

Abbott Laboratories 33

Clinical Trial Overview of Abbott Laboratories 33

Forest Laboratories, Inc. 35

Clinical Trial Overview of Forest Laboratories, Inc. 35

Digestive Care, Inc. 36

Clinical Trial Overview of Digestive Care, Inc. 36

DATAMAP GmbH 37

Clinical Trial Overview of DATAMAP GmbH 37

Parexel International Corporation 38

Clinical Trial Overview of Parexel International Corporation 38

Anthera Pharmaceuticals Inc. 39

Clinical Trial Overview of Anthera Pharmaceuticals Inc. 39

LAL Clinica Pesquisa e Desenvolvimento Ltda 40

Clinical Trial Overview of LAL Clinica Pesquisa e Desenvolvimento Ltda 40

Johnson & Johnson 41

Clinical Trial Overview of Johnson & Johnson 41

Axcan Pharma Inc. 42

Clinical Trial Overview of Axcan Pharma Inc. 42

AbbVie Inc. 43

Clinical Trial Overview of AbbVie Inc. 43

Clinical Trial Overview of Top Institutes / Government 44

Fundacion para la Investigacion en Enfermedades Del Aparato Digestivo 44

Clinical Trial Overview of Fundacion para la Investigacion en Enfermedades Del Aparato Digestivo 44

The Foundation for Liver Research 45

Clinical Trial Overview of The Foundation for Liver Research 45

University of Pennsylvania 46

Clinical Trial Overview of University of Pennsylvania 46

Azienda Ospedaliera Universitaria Integrata Verona 47

Clinical Trial Overview of Azienda Ospedaliera Universitaria Integrata Verona 47

Calvary Mater Newcastle 48

Clinical Trial Overview of Calvary Mater Newcastle 48

Columbia University 49

Clinical Trial Overview of Columbia University 49

Seattle Children's Hospital 50

Clinical Trial Overview of Seattle Children's Hospital 50

Sheffield Teaching Hospitals NHS Foundation Trust 51

Clinical Trial Overview of Sheffield Teaching Hospitals NHS Foundation Trust 51

Texas A&M University 52

Clinical Trial Overview of Texas A&M University 52

The University of Tokyo 53

Clinical Trial Overview of The University of Tokyo 53

Five Key Clinical Profiles 54

Appendix 87

Abbreviations 87

Definitions 87

Research Methodology 88

Secondary Research 88

About GlobalData 89

Contact Us 89

Disclaimer 89

Source 89

List of Figures

Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15

Exocrine Pancreatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Exocrine Pancreatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18

Exocrine Pancreatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Exocrine Pancreatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Exocrine Pancreatic Insufficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

GlobalData Methodology 88

List of Tables

Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials by Region, 2015* 7

Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15

Exocrine Pancreatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Exocrine Pancreatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Exocrine Pancreatic Insufficiency to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18

Exocrine Pancreatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Exocrine Pancreatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Exocrine Pancreatic Insufficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Exocrine Pancreatic Insufficiency Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Exocrine Pancreatic Insufficiency Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Exocrine Pancreatic Insufficiency Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Exocrine Pancreatic Insufficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015* 33

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2015* 35

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Digestive Care, Inc., 2015* 36

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by DATAMAP GmbH, 2015* 37

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Parexel International Corporation, 2015* 38

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Anthera Pharmaceuticals Inc., 2015* 39

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by LAL Clinica Pesquisa e Desenvolvimento Ltda, 2015* 40

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 41

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Axcan Pharma Inc., 2015* 42

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 43

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacion para la Investigacion en Enfermedades Del Aparato Digestivo, 2015* 44

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by The Foundation for Liver Research, 2015* 45

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2015* 46

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Universitaria Integrata Verona, 2015* 47

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Calvary Mater Newcastle, 2015* 48

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2015* 49

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Children's Hospital, 2015* 50

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Sheffield Teaching Hospitals NHS Foundation Trust, 2015* 51

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Texas A&M University, 2015* 52

Exocrine Pancreatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2015* 53

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Exocrine Pancreatic Insufficiency Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Exocrine Pancreatic Insufficiency, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 162625
Site License
USD 5000 INR 325250
Corporate User License
USD 7500 INR 487875

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com